carbetocin 100 µg
DrugHemodynamic effect of
Other names: Pabal, injection
NCT Number: NCT00977769
A randomized double-blind trial of oxytocin 5 u, carbetocin 100 µg and placebo with hemodynamic response as a primary outcome measure.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Phase 4
Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway
Healthy pregnant women sheduled for elective cesarean section. Invasive hemodynmaic monitoring with LiDCO Plus.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hemodynamic effect of
Other names: Pabal, injection
Hemodynamic effect of
Other names: Syntocinon, injection
Hemodynamic effect of
Other names: Saline, injection
Time frame: 2.5 minutes
The relative change in CO from baseline at the time of delivery up to 2.5 minutes post delivery.
Time frame: 2.5 min
The mean change in SAP compared with baseline at the time of delivery up to 2.5 minutes post delivery.
Time frame: 120 minutes
The calculated estimated blood loss from delivery until 2 h after intervention
Oslo University Hospital
Other
Hemodynamic Effects of Carbetocin 100 µg, Oxytocin 5 U or Placebo After Cesarean Delivery Under Spinal Anesthesia in Healthy Pregnant Women.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.